Insider filing · BCAX
Lara Meisner
Chief Legal Officer
profile →
Bicara Therapeutics Inc.
BCAX · Healthcare · 40 filings in 24 months
ticker →
Lara Meisner sold $1.0M of Bicara Therapeutics (BCAX)
Executed Mar 14 2025, disclosed Mar 18 2025, 4 days later.
Value, as filed
$1.0M
79,146 sh across 2 lots
Executed
Mar 14 2025
the trade date, as filed
Disclosed
Mar 18 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
LMLara Meisner (Chief Legal Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Bicara Therapeutics Inc. (BCAX). The largest single filing was $499K of BCAX (33,807 sh × $14.75, as filed), executed Sep 29 2025.
The name
BCAXHealthcare · Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Lara Meisner in BCAX
BCAXSALE
Bicara Therapeutics Inc.
$499K33,807 sh × $14.75
Exec Sep 29 2025
Filed Oct 1 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $182K
15,829 sh × $11.49
Exec Sep 15 2025
Filed Sep 17 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $165K
15,829 sh × $10.43
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET